Navigation Links
International Aid Named as a MinistryWatch.com 'Shining Light' Christian Ministry
Date:12/17/2007

Agency Ranked Among Top 30 U.S. Ministries for Third Consecutive Year

SPRING LAKE, Mich., Dec. 17 /PRNewswire-USNewswire/ -- Leading humanitarian health care agency International Aid has been named to MinistryWatch.com's list of Top 30 "Shining Light" Christian Ministries for 2007. This is the third consecutive year International Aid has been included in the list.

MinistryWatch.com is an online database that reviews the operations of more than 400 of the largest Christian ministries and charitable organizations in the United States. International Aid was selected for a number of key factors, including the agency's compelling mission and purpose, its relief and development efforts around the globe, and its financial stewardship and transparency. MinistryWatch.com assigned International Aid a five-star financial efficiency rating and ranked the organization 14th out of 434 ministries in its database.

MinistryWatch.com's annual list serves as a resource to help individuals determine how to allocate their giving. The website is viewed by more than 30,000 unique visitors each month, and has been featured in The Wall Street Journal, The Washington Post, The New York Times, major television and radio networks, and scores of local and Christian media outlets.

"We are delighted to be named one of MinistryWatch.com's 'Shining Lights' for the third consecutive year," said Myles D. Fish, International Aid's president and CEO. "This honor underscores our ongoing commitment to being a responsible steward of our supporters' gifts, as well as the growing impact International Aid is making in communities all around the globe."

The full list of 2007 "Shining Light" Ministries is available online at http://www.ministrywatch.com.

About International Aid

International Aid is a leading Christian relief and development agency that provides and supports solutions in healthcare. O
'/>"/>

SOURCE International Aid
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks 2Health News:Physical Therapist, Money Launderer and Patient Recruiter Plead Guilty in Connection With Multiple Detroit Health Care Fraud Schemes 2Health News:Physical Therapist, Money Launderer and Patient Recruiter Plead Guilty in Connection With Multiple Detroit Health Care Fraud Schemes 3Health News:Physical Therapist, Money Launderer and Patient Recruiter Plead Guilty in Connection With Multiple Detroit Health Care Fraud Schemes 4Health News:Fertility Fact vs. Fiction: Women Recognizing Age as a Major Obstacle 2Health News:Fertility Fact vs. Fiction: Women Recognizing Age as a Major Obstacle 3Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 2Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 3Health News:Kaiser Permanente Gives $5 Million to Children's Healthcare of Atlanta 2Health News:Kaiser Permanente Gives $5 Million to Children's Healthcare of Atlanta 3
Other Medicine News:Health News:UC San Diego researchers target tumors with tiny 'nanoworms' 2Health News:UC San Diego researchers target tumors with tiny 'nanoworms' 3Health News:Kaiser Permanente's Appointment and Advice Call Center Improves Employee Coaching and Development Activities 2Health News:CVS Joins Retail Push for Non-Toxic Personal Care Products 2Health News:CVS Joins Retail Push for Non-Toxic Personal Care Products 3Health News:'The Polyamory Handbook': New Guide Covers Entire Spectrum of Rapidly Growing Relationship Style 2Health News:Smart Balance Announces 2008 First-Quarter Results 2Health News:Smart Balance Announces 2008 First-Quarter Results 3Health News:Smart Balance Announces 2008 First-Quarter Results 4Health News:Smart Balance Announces 2008 First-Quarter Results 5Health News:Smart Balance Announces 2008 First-Quarter Results 6Health News:Smart Balance Announces 2008 First-Quarter Results 7Health News:Smart Balance Announces 2008 First-Quarter Results 8Health News:Smart Balance Announces 2008 First-Quarter Results 9Health News:Smart Balance Announces 2008 First-Quarter Results 10Health News:Smart Balance Announces 2008 First-Quarter Results 11Health News:Smart Balance Announces 2008 First-Quarter Results 12Health News:AIDS.gov Goes 2.0: Government HIV/AIDS Website Now Features a Blog, Podcasts, and More 2
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 48082 1Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 48082 2Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 48082 3Researchers Uncover Why Turmeric Helps Heal 48078 1Chandler Chicco Companies Announces New Brandtectonics Access US Offering 48073 1Chandler Chicco Companies Announces New Brandtectonics Access US Offering 48073 2Chandler Chicco Companies Announces New Brandtectonics Access US Offering 48073 3